Hicin Pharmaceutical
30058431.480.90% ( +0.28 )
Hicin Pharmaceutical (300584)
Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, API...
- Open
- 31.02
- High
- 32.24
- Low
- 31.00
- Prev. Close
- 31.20
- Volume
- 25.58K
- Turnover
- 81.13M
- Avg Price
- 31.71
- Bid/Ask Ratio
- --
- Amplitude
- 3.97%
- 52wk High
- 81.78
- Volume Ratio
- 0.78
- Turnover Ratio
- 2.13%
Hicin Pharmaceutical Analyst Rating
View MoreForecast & Rating
Apr 9, 2020Price forecast
--100.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 27, 2025 at 09:10 PM
The solid-state battery concept fluctuates and strengthens, GMK rises over 15%
- Zhitong · Oct 26, 2025 at 10:38 PM
On October 27th, Hicin Pharmaceutical stated on the interactive platform that the company's lithium sulfide project has completed the pilot line construction as planned and is orderly advancing the trial production work
- Zhitong · Oct 22, 2025 at 03:57 AM
Hicin Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 32.6785 million yuan, a year-on-year increase of 16.22%
- Zhitong · Oct 22, 2025 at 03:36 AM
Hicin Pharmaceutical: The net profit attributable to the parent company in the third quarter was 3.5208 million yuan, a year-on-year increase of 4.15%
- Zhitong · Sep 17, 2025 at 02:58 AM
Hicin Pharmaceutical: Will send representatives to attend the Hefei Solid-State Battery Conference in October
- Zhitong · Sep 4, 2025 at 09:48 PM
Innovative drug concept experiences a surge, JOINN hits the daily limit up
